Che-Hsuan Lin Selected Research

Che-Hsuan Lin Research Topics

9	Neoplasms (Cancer) 01/2024 - 09/2019
2	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2024 - 09/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 03/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2019
2	Triple Negative Breast Neoplasms 01/2020 - 01/2020
1	Infections 02/2024
1	Adenocarcinoma of Lung 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Mouth Neoplasms (Oral Cancer) 09/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019
1	Pathologic Complete Response 10/2018
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2018
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2020
2	MTOR InhibitorsIBA 12/2021 - 03/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 12/2019
2	Histones (Histone)IBA 01/2020 - 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Carrier Proteins (Binding Protein)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 03/2023
1	InflammasomesIBA 01/2023
1	LactoferrinIBA 12/2021
1	DNA Polymerase thetaIBA 12/2020
1	Therapeutic UsesIBA 12/2020
1	Docetaxel (Taxotere)FDA Link 12/2020
1	InterferonsIBA 09/2020
1	LuciferasesIBA 09/2020
1	Estrogen ReceptorsIBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	AnthracyclinesIBA 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2018